Gene Editing, Enhancing and Women’s Role
Abstract A recent article on the front page of The Independent (September 18, 2015) reported that the genetic ‘manipulation’ of IVF embryos is to start in Britain, using a new revolutionary gene-editing technique, called Crispr/Cas9. About three weeks later (Saturday 10, October 2015), on the front...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Simonstein, Frida [verfasserIn] |
|---|
| Format: |
Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2017 |
|---|
| Schlagwörter: |
|---|
| Anmerkung: |
© Springer Science+Business Media Dordrecht 2017 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Science and engineering ethics - Springer Netherlands, 1995, 25(2017), 4 vom: 02. Feb., Seite 1007-1016 |
|---|---|
| Übergeordnetes Werk: |
volume:25 ; year:2017 ; number:4 ; day:02 ; month:02 ; pages:1007-1016 |
| Links: |
|---|
| DOI / URN: |
10.1007/s11948-017-9875-5 |
|---|
| Katalog-ID: |
OLC202918070X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC202918070X | ||
| 003 | DE-627 | ||
| 005 | 20230402075631.0 | ||
| 007 | tu | ||
| 008 | 200819s2017 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s11948-017-9875-5 |2 doi | |
| 035 | |a (DE-627)OLC202918070X | ||
| 035 | |a (DE-He213)s11948-017-9875-5-p | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 100 |a 500 |q VZ |
| 084 | |a 19,2 |2 ssgn | ||
| 100 | 1 | |a Simonstein, Frida |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Gene Editing, Enhancing and Women’s Role |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a © Springer Science+Business Media Dordrecht 2017 | ||
| 520 | |a Abstract A recent article on the front page of The Independent (September 18, 2015) reported that the genetic ‘manipulation’ of IVF embryos is to start in Britain, using a new revolutionary gene-editing technique, called Crispr/Cas9. About three weeks later (Saturday 10, October 2015), on the front page of the same newspaper, it was reported that the National Health Service (NHS) faces a one billion pound deficit only 3 months into the new year. The hidden connection between these reports is that gene editing could be used to solve issues related to health care allocation. Improving the health of future generations might coincide with public health goals; it might improve the health of individuals and communities, and, if successful, might be seen as a public good. However, enhancing future generations will require In Vitro Fertilisation and Pre-implantation Genetic Diagnosis. Remarkably, the necessary involvement of women in an enhancing scenario has not been discussed by its proponents. The present discourse on moral obligations of future generations, although not referring to women, seems to imply that women might be required, morally, if not legally, to reproduce with IVF. Enhancing future generations will be gendered, unless the artificial womb is developed. These are challenging issues that require a wider perspective, of both women and men. Despite the lack of a unified feminist conclusion in the discussions about the merits and risks of human genome modification, there is an urgent need to clarify the role of women in this scenario. | ||
| 650 | 4 | |a Genetics | |
| 650 | 4 | |a Reproduction | |
| 650 | 4 | |a Health care allocation | |
| 650 | 4 | |a IVF | |
| 650 | 4 | |a PGD | |
| 650 | 4 | |a Ectogenesis | |
| 773 | 0 | 8 | |i Enthalten in |t Science and engineering ethics |d Springer Netherlands, 1995 |g 25(2017), 4 vom: 02. Feb., Seite 1007-1016 |w (DE-627)19230397X |w (DE-600)1304534-9 |w (DE-576)051378167 |x 1353-3452 |7 nnns |
| 773 | 1 | 8 | |g volume:25 |g year:2017 |g number:4 |g day:02 |g month:02 |g pages:1007-1016 |
| 856 | 4 | 1 | |u https://doi.org/10.1007/s11948-017-9875-5 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-TEC | ||
| 912 | |a SSG-OLC-PHY | ||
| 912 | |a SSG-OLC-CHE | ||
| 912 | |a SSG-OLC-MAT | ||
| 912 | |a SSG-OLC-TGE | ||
| 912 | |a GBV_ILN_70 | ||
| 951 | |a AR | ||
| 952 | |d 25 |j 2017 |e 4 |b 02 |c 02 |h 1007-1016 | ||
| author_variant |
f s fs |
|---|---|
| matchkey_str |
article:13533452:2017----::eedtnehnignw |
| hierarchy_sort_str |
2017 |
| publishDate |
2017 |
| allfields |
10.1007/s11948-017-9875-5 doi (DE-627)OLC202918070X (DE-He213)s11948-017-9875-5-p DE-627 ger DE-627 rakwb eng 100 500 VZ 19,2 ssgn Simonstein, Frida verfasserin aut Gene Editing, Enhancing and Women’s Role 2017 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier © Springer Science+Business Media Dordrecht 2017 Abstract A recent article on the front page of The Independent (September 18, 2015) reported that the genetic ‘manipulation’ of IVF embryos is to start in Britain, using a new revolutionary gene-editing technique, called Crispr/Cas9. About three weeks later (Saturday 10, October 2015), on the front page of the same newspaper, it was reported that the National Health Service (NHS) faces a one billion pound deficit only 3 months into the new year. The hidden connection between these reports is that gene editing could be used to solve issues related to health care allocation. Improving the health of future generations might coincide with public health goals; it might improve the health of individuals and communities, and, if successful, might be seen as a public good. However, enhancing future generations will require In Vitro Fertilisation and Pre-implantation Genetic Diagnosis. Remarkably, the necessary involvement of women in an enhancing scenario has not been discussed by its proponents. The present discourse on moral obligations of future generations, although not referring to women, seems to imply that women might be required, morally, if not legally, to reproduce with IVF. Enhancing future generations will be gendered, unless the artificial womb is developed. These are challenging issues that require a wider perspective, of both women and men. Despite the lack of a unified feminist conclusion in the discussions about the merits and risks of human genome modification, there is an urgent need to clarify the role of women in this scenario. Genetics Reproduction Health care allocation IVF PGD Ectogenesis Enthalten in Science and engineering ethics Springer Netherlands, 1995 25(2017), 4 vom: 02. Feb., Seite 1007-1016 (DE-627)19230397X (DE-600)1304534-9 (DE-576)051378167 1353-3452 nnns volume:25 year:2017 number:4 day:02 month:02 pages:1007-1016 https://doi.org/10.1007/s11948-017-9875-5 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-TEC SSG-OLC-PHY SSG-OLC-CHE SSG-OLC-MAT SSG-OLC-TGE GBV_ILN_70 AR 25 2017 4 02 02 1007-1016 |
| spelling |
10.1007/s11948-017-9875-5 doi (DE-627)OLC202918070X (DE-He213)s11948-017-9875-5-p DE-627 ger DE-627 rakwb eng 100 500 VZ 19,2 ssgn Simonstein, Frida verfasserin aut Gene Editing, Enhancing and Women’s Role 2017 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier © Springer Science+Business Media Dordrecht 2017 Abstract A recent article on the front page of The Independent (September 18, 2015) reported that the genetic ‘manipulation’ of IVF embryos is to start in Britain, using a new revolutionary gene-editing technique, called Crispr/Cas9. About three weeks later (Saturday 10, October 2015), on the front page of the same newspaper, it was reported that the National Health Service (NHS) faces a one billion pound deficit only 3 months into the new year. The hidden connection between these reports is that gene editing could be used to solve issues related to health care allocation. Improving the health of future generations might coincide with public health goals; it might improve the health of individuals and communities, and, if successful, might be seen as a public good. However, enhancing future generations will require In Vitro Fertilisation and Pre-implantation Genetic Diagnosis. Remarkably, the necessary involvement of women in an enhancing scenario has not been discussed by its proponents. The present discourse on moral obligations of future generations, although not referring to women, seems to imply that women might be required, morally, if not legally, to reproduce with IVF. Enhancing future generations will be gendered, unless the artificial womb is developed. These are challenging issues that require a wider perspective, of both women and men. Despite the lack of a unified feminist conclusion in the discussions about the merits and risks of human genome modification, there is an urgent need to clarify the role of women in this scenario. Genetics Reproduction Health care allocation IVF PGD Ectogenesis Enthalten in Science and engineering ethics Springer Netherlands, 1995 25(2017), 4 vom: 02. Feb., Seite 1007-1016 (DE-627)19230397X (DE-600)1304534-9 (DE-576)051378167 1353-3452 nnns volume:25 year:2017 number:4 day:02 month:02 pages:1007-1016 https://doi.org/10.1007/s11948-017-9875-5 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-TEC SSG-OLC-PHY SSG-OLC-CHE SSG-OLC-MAT SSG-OLC-TGE GBV_ILN_70 AR 25 2017 4 02 02 1007-1016 |
| allfields_unstemmed |
10.1007/s11948-017-9875-5 doi (DE-627)OLC202918070X (DE-He213)s11948-017-9875-5-p DE-627 ger DE-627 rakwb eng 100 500 VZ 19,2 ssgn Simonstein, Frida verfasserin aut Gene Editing, Enhancing and Women’s Role 2017 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier © Springer Science+Business Media Dordrecht 2017 Abstract A recent article on the front page of The Independent (September 18, 2015) reported that the genetic ‘manipulation’ of IVF embryos is to start in Britain, using a new revolutionary gene-editing technique, called Crispr/Cas9. About three weeks later (Saturday 10, October 2015), on the front page of the same newspaper, it was reported that the National Health Service (NHS) faces a one billion pound deficit only 3 months into the new year. The hidden connection between these reports is that gene editing could be used to solve issues related to health care allocation. Improving the health of future generations might coincide with public health goals; it might improve the health of individuals and communities, and, if successful, might be seen as a public good. However, enhancing future generations will require In Vitro Fertilisation and Pre-implantation Genetic Diagnosis. Remarkably, the necessary involvement of women in an enhancing scenario has not been discussed by its proponents. The present discourse on moral obligations of future generations, although not referring to women, seems to imply that women might be required, morally, if not legally, to reproduce with IVF. Enhancing future generations will be gendered, unless the artificial womb is developed. These are challenging issues that require a wider perspective, of both women and men. Despite the lack of a unified feminist conclusion in the discussions about the merits and risks of human genome modification, there is an urgent need to clarify the role of women in this scenario. Genetics Reproduction Health care allocation IVF PGD Ectogenesis Enthalten in Science and engineering ethics Springer Netherlands, 1995 25(2017), 4 vom: 02. Feb., Seite 1007-1016 (DE-627)19230397X (DE-600)1304534-9 (DE-576)051378167 1353-3452 nnns volume:25 year:2017 number:4 day:02 month:02 pages:1007-1016 https://doi.org/10.1007/s11948-017-9875-5 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-TEC SSG-OLC-PHY SSG-OLC-CHE SSG-OLC-MAT SSG-OLC-TGE GBV_ILN_70 AR 25 2017 4 02 02 1007-1016 |
| allfieldsGer |
10.1007/s11948-017-9875-5 doi (DE-627)OLC202918070X (DE-He213)s11948-017-9875-5-p DE-627 ger DE-627 rakwb eng 100 500 VZ 19,2 ssgn Simonstein, Frida verfasserin aut Gene Editing, Enhancing and Women’s Role 2017 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier © Springer Science+Business Media Dordrecht 2017 Abstract A recent article on the front page of The Independent (September 18, 2015) reported that the genetic ‘manipulation’ of IVF embryos is to start in Britain, using a new revolutionary gene-editing technique, called Crispr/Cas9. About three weeks later (Saturday 10, October 2015), on the front page of the same newspaper, it was reported that the National Health Service (NHS) faces a one billion pound deficit only 3 months into the new year. The hidden connection between these reports is that gene editing could be used to solve issues related to health care allocation. Improving the health of future generations might coincide with public health goals; it might improve the health of individuals and communities, and, if successful, might be seen as a public good. However, enhancing future generations will require In Vitro Fertilisation and Pre-implantation Genetic Diagnosis. Remarkably, the necessary involvement of women in an enhancing scenario has not been discussed by its proponents. The present discourse on moral obligations of future generations, although not referring to women, seems to imply that women might be required, morally, if not legally, to reproduce with IVF. Enhancing future generations will be gendered, unless the artificial womb is developed. These are challenging issues that require a wider perspective, of both women and men. Despite the lack of a unified feminist conclusion in the discussions about the merits and risks of human genome modification, there is an urgent need to clarify the role of women in this scenario. Genetics Reproduction Health care allocation IVF PGD Ectogenesis Enthalten in Science and engineering ethics Springer Netherlands, 1995 25(2017), 4 vom: 02. Feb., Seite 1007-1016 (DE-627)19230397X (DE-600)1304534-9 (DE-576)051378167 1353-3452 nnns volume:25 year:2017 number:4 day:02 month:02 pages:1007-1016 https://doi.org/10.1007/s11948-017-9875-5 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-TEC SSG-OLC-PHY SSG-OLC-CHE SSG-OLC-MAT SSG-OLC-TGE GBV_ILN_70 AR 25 2017 4 02 02 1007-1016 |
| allfieldsSound |
10.1007/s11948-017-9875-5 doi (DE-627)OLC202918070X (DE-He213)s11948-017-9875-5-p DE-627 ger DE-627 rakwb eng 100 500 VZ 19,2 ssgn Simonstein, Frida verfasserin aut Gene Editing, Enhancing and Women’s Role 2017 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier © Springer Science+Business Media Dordrecht 2017 Abstract A recent article on the front page of The Independent (September 18, 2015) reported that the genetic ‘manipulation’ of IVF embryos is to start in Britain, using a new revolutionary gene-editing technique, called Crispr/Cas9. About three weeks later (Saturday 10, October 2015), on the front page of the same newspaper, it was reported that the National Health Service (NHS) faces a one billion pound deficit only 3 months into the new year. The hidden connection between these reports is that gene editing could be used to solve issues related to health care allocation. Improving the health of future generations might coincide with public health goals; it might improve the health of individuals and communities, and, if successful, might be seen as a public good. However, enhancing future generations will require In Vitro Fertilisation and Pre-implantation Genetic Diagnosis. Remarkably, the necessary involvement of women in an enhancing scenario has not been discussed by its proponents. The present discourse on moral obligations of future generations, although not referring to women, seems to imply that women might be required, morally, if not legally, to reproduce with IVF. Enhancing future generations will be gendered, unless the artificial womb is developed. These are challenging issues that require a wider perspective, of both women and men. Despite the lack of a unified feminist conclusion in the discussions about the merits and risks of human genome modification, there is an urgent need to clarify the role of women in this scenario. Genetics Reproduction Health care allocation IVF PGD Ectogenesis Enthalten in Science and engineering ethics Springer Netherlands, 1995 25(2017), 4 vom: 02. Feb., Seite 1007-1016 (DE-627)19230397X (DE-600)1304534-9 (DE-576)051378167 1353-3452 nnns volume:25 year:2017 number:4 day:02 month:02 pages:1007-1016 https://doi.org/10.1007/s11948-017-9875-5 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-TEC SSG-OLC-PHY SSG-OLC-CHE SSG-OLC-MAT SSG-OLC-TGE GBV_ILN_70 AR 25 2017 4 02 02 1007-1016 |
| language |
English |
| source |
Enthalten in Science and engineering ethics 25(2017), 4 vom: 02. Feb., Seite 1007-1016 volume:25 year:2017 number:4 day:02 month:02 pages:1007-1016 |
| sourceStr |
Enthalten in Science and engineering ethics 25(2017), 4 vom: 02. Feb., Seite 1007-1016 volume:25 year:2017 number:4 day:02 month:02 pages:1007-1016 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Genetics Reproduction Health care allocation IVF PGD Ectogenesis |
| dewey-raw |
100 |
| isfreeaccess_bool |
false |
| container_title |
Science and engineering ethics |
| authorswithroles_txt_mv |
Simonstein, Frida @@aut@@ |
| publishDateDaySort_date |
2017-02-02T00:00:00Z |
| hierarchy_top_id |
19230397X |
| dewey-sort |
3100 |
| id |
OLC202918070X |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">OLC202918070X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230402075631.0</controlfield><controlfield tag="007">tu</controlfield><controlfield tag="008">200819s2017 xx ||||| 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s11948-017-9875-5</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)OLC202918070X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-He213)s11948-017-9875-5-p</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">100</subfield><subfield code="a">500</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">19,2</subfield><subfield code="2">ssgn</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Simonstein, Frida</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Gene Editing, Enhancing and Women’s Role</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">ohne Hilfsmittel zu benutzen</subfield><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Band</subfield><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Springer Science+Business Media Dordrecht 2017</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract A recent article on the front page of The Independent (September 18, 2015) reported that the genetic ‘manipulation’ of IVF embryos is to start in Britain, using a new revolutionary gene-editing technique, called Crispr/Cas9. About three weeks later (Saturday 10, October 2015), on the front page of the same newspaper, it was reported that the National Health Service (NHS) faces a one billion pound deficit only 3 months into the new year. The hidden connection between these reports is that gene editing could be used to solve issues related to health care allocation. Improving the health of future generations might coincide with public health goals; it might improve the health of individuals and communities, and, if successful, might be seen as a public good. However, enhancing future generations will require In Vitro Fertilisation and Pre-implantation Genetic Diagnosis. Remarkably, the necessary involvement of women in an enhancing scenario has not been discussed by its proponents. The present discourse on moral obligations of future generations, although not referring to women, seems to imply that women might be required, morally, if not legally, to reproduce with IVF. Enhancing future generations will be gendered, unless the artificial womb is developed. These are challenging issues that require a wider perspective, of both women and men. Despite the lack of a unified feminist conclusion in the discussions about the merits and risks of human genome modification, there is an urgent need to clarify the role of women in this scenario.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Genetics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Reproduction</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Health care allocation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">IVF</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">PGD</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ectogenesis</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Science and engineering ethics</subfield><subfield code="d">Springer Netherlands, 1995</subfield><subfield code="g">25(2017), 4 vom: 02. Feb., Seite 1007-1016</subfield><subfield code="w">(DE-627)19230397X</subfield><subfield code="w">(DE-600)1304534-9</subfield><subfield code="w">(DE-576)051378167</subfield><subfield code="x">1353-3452</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:25</subfield><subfield code="g">year:2017</subfield><subfield code="g">number:4</subfield><subfield code="g">day:02</subfield><subfield code="g">month:02</subfield><subfield code="g">pages:1007-1016</subfield></datafield><datafield tag="856" ind1="4" ind2="1"><subfield code="u">https://doi.org/10.1007/s11948-017-9875-5</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_OLC</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-TEC</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-CHE</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-MAT</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-TGE</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">25</subfield><subfield code="j">2017</subfield><subfield code="e">4</subfield><subfield code="b">02</subfield><subfield code="c">02</subfield><subfield code="h">1007-1016</subfield></datafield></record></collection>
|
| author |
Simonstein, Frida |
| spellingShingle |
Simonstein, Frida ddc 100 ssgn 19,2 misc Genetics misc Reproduction misc Health care allocation misc IVF misc PGD misc Ectogenesis Gene Editing, Enhancing and Women’s Role |
| authorStr |
Simonstein, Frida |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)19230397X |
| format |
Article |
| dewey-ones |
100 - Philosophy & psychology 500 - Natural sciences & mathematics |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
OLC |
| remote_str |
false |
| illustrated |
Not Illustrated |
| issn |
1353-3452 |
| topic_title |
100 500 VZ 19,2 ssgn Gene Editing, Enhancing and Women’s Role Genetics Reproduction Health care allocation IVF PGD Ectogenesis |
| topic |
ddc 100 ssgn 19,2 misc Genetics misc Reproduction misc Health care allocation misc IVF misc PGD misc Ectogenesis |
| topic_unstemmed |
ddc 100 ssgn 19,2 misc Genetics misc Reproduction misc Health care allocation misc IVF misc PGD misc Ectogenesis |
| topic_browse |
ddc 100 ssgn 19,2 misc Genetics misc Reproduction misc Health care allocation misc IVF misc PGD misc Ectogenesis |
| format_facet |
Aufsätze Gedruckte Aufsätze |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
nc |
| hierarchy_parent_title |
Science and engineering ethics |
| hierarchy_parent_id |
19230397X |
| dewey-tens |
100 - Philosophy 500 - Science |
| hierarchy_top_title |
Science and engineering ethics |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)19230397X (DE-600)1304534-9 (DE-576)051378167 |
| title |
Gene Editing, Enhancing and Women’s Role |
| ctrlnum |
(DE-627)OLC202918070X (DE-He213)s11948-017-9875-5-p |
| title_full |
Gene Editing, Enhancing and Women’s Role |
| author_sort |
Simonstein, Frida |
| journal |
Science and engineering ethics |
| journalStr |
Science and engineering ethics |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
100 - Philosophy & psychology 500 - Science |
| recordtype |
marc |
| publishDateSort |
2017 |
| contenttype_str_mv |
txt |
| container_start_page |
1007 |
| author_browse |
Simonstein, Frida |
| container_volume |
25 |
| class |
100 500 VZ 19,2 ssgn |
| format_se |
Aufsätze |
| author-letter |
Simonstein, Frida |
| doi_str_mv |
10.1007/s11948-017-9875-5 |
| dewey-full |
100 500 |
| title_sort |
gene editing, enhancing and women’s role |
| title_auth |
Gene Editing, Enhancing and Women’s Role |
| abstract |
Abstract A recent article on the front page of The Independent (September 18, 2015) reported that the genetic ‘manipulation’ of IVF embryos is to start in Britain, using a new revolutionary gene-editing technique, called Crispr/Cas9. About three weeks later (Saturday 10, October 2015), on the front page of the same newspaper, it was reported that the National Health Service (NHS) faces a one billion pound deficit only 3 months into the new year. The hidden connection between these reports is that gene editing could be used to solve issues related to health care allocation. Improving the health of future generations might coincide with public health goals; it might improve the health of individuals and communities, and, if successful, might be seen as a public good. However, enhancing future generations will require In Vitro Fertilisation and Pre-implantation Genetic Diagnosis. Remarkably, the necessary involvement of women in an enhancing scenario has not been discussed by its proponents. The present discourse on moral obligations of future generations, although not referring to women, seems to imply that women might be required, morally, if not legally, to reproduce with IVF. Enhancing future generations will be gendered, unless the artificial womb is developed. These are challenging issues that require a wider perspective, of both women and men. Despite the lack of a unified feminist conclusion in the discussions about the merits and risks of human genome modification, there is an urgent need to clarify the role of women in this scenario. © Springer Science+Business Media Dordrecht 2017 |
| abstractGer |
Abstract A recent article on the front page of The Independent (September 18, 2015) reported that the genetic ‘manipulation’ of IVF embryos is to start in Britain, using a new revolutionary gene-editing technique, called Crispr/Cas9. About three weeks later (Saturday 10, October 2015), on the front page of the same newspaper, it was reported that the National Health Service (NHS) faces a one billion pound deficit only 3 months into the new year. The hidden connection between these reports is that gene editing could be used to solve issues related to health care allocation. Improving the health of future generations might coincide with public health goals; it might improve the health of individuals and communities, and, if successful, might be seen as a public good. However, enhancing future generations will require In Vitro Fertilisation and Pre-implantation Genetic Diagnosis. Remarkably, the necessary involvement of women in an enhancing scenario has not been discussed by its proponents. The present discourse on moral obligations of future generations, although not referring to women, seems to imply that women might be required, morally, if not legally, to reproduce with IVF. Enhancing future generations will be gendered, unless the artificial womb is developed. These are challenging issues that require a wider perspective, of both women and men. Despite the lack of a unified feminist conclusion in the discussions about the merits and risks of human genome modification, there is an urgent need to clarify the role of women in this scenario. © Springer Science+Business Media Dordrecht 2017 |
| abstract_unstemmed |
Abstract A recent article on the front page of The Independent (September 18, 2015) reported that the genetic ‘manipulation’ of IVF embryos is to start in Britain, using a new revolutionary gene-editing technique, called Crispr/Cas9. About three weeks later (Saturday 10, October 2015), on the front page of the same newspaper, it was reported that the National Health Service (NHS) faces a one billion pound deficit only 3 months into the new year. The hidden connection between these reports is that gene editing could be used to solve issues related to health care allocation. Improving the health of future generations might coincide with public health goals; it might improve the health of individuals and communities, and, if successful, might be seen as a public good. However, enhancing future generations will require In Vitro Fertilisation and Pre-implantation Genetic Diagnosis. Remarkably, the necessary involvement of women in an enhancing scenario has not been discussed by its proponents. The present discourse on moral obligations of future generations, although not referring to women, seems to imply that women might be required, morally, if not legally, to reproduce with IVF. Enhancing future generations will be gendered, unless the artificial womb is developed. These are challenging issues that require a wider perspective, of both women and men. Despite the lack of a unified feminist conclusion in the discussions about the merits and risks of human genome modification, there is an urgent need to clarify the role of women in this scenario. © Springer Science+Business Media Dordrecht 2017 |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-TEC SSG-OLC-PHY SSG-OLC-CHE SSG-OLC-MAT SSG-OLC-TGE GBV_ILN_70 |
| container_issue |
4 |
| title_short |
Gene Editing, Enhancing and Women’s Role |
| url |
https://doi.org/10.1007/s11948-017-9875-5 |
| remote_bool |
false |
| ppnlink |
19230397X |
| mediatype_str_mv |
n |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| doi_str |
10.1007/s11948-017-9875-5 |
| up_date |
2024-07-03T22:00:07.295Z |
| _version_ |
1803596865003847680 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">OLC202918070X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230402075631.0</controlfield><controlfield tag="007">tu</controlfield><controlfield tag="008">200819s2017 xx ||||| 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s11948-017-9875-5</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)OLC202918070X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-He213)s11948-017-9875-5-p</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">100</subfield><subfield code="a">500</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">19,2</subfield><subfield code="2">ssgn</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Simonstein, Frida</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Gene Editing, Enhancing and Women’s Role</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">ohne Hilfsmittel zu benutzen</subfield><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Band</subfield><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Springer Science+Business Media Dordrecht 2017</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract A recent article on the front page of The Independent (September 18, 2015) reported that the genetic ‘manipulation’ of IVF embryos is to start in Britain, using a new revolutionary gene-editing technique, called Crispr/Cas9. About three weeks later (Saturday 10, October 2015), on the front page of the same newspaper, it was reported that the National Health Service (NHS) faces a one billion pound deficit only 3 months into the new year. The hidden connection between these reports is that gene editing could be used to solve issues related to health care allocation. Improving the health of future generations might coincide with public health goals; it might improve the health of individuals and communities, and, if successful, might be seen as a public good. However, enhancing future generations will require In Vitro Fertilisation and Pre-implantation Genetic Diagnosis. Remarkably, the necessary involvement of women in an enhancing scenario has not been discussed by its proponents. The present discourse on moral obligations of future generations, although not referring to women, seems to imply that women might be required, morally, if not legally, to reproduce with IVF. Enhancing future generations will be gendered, unless the artificial womb is developed. These are challenging issues that require a wider perspective, of both women and men. Despite the lack of a unified feminist conclusion in the discussions about the merits and risks of human genome modification, there is an urgent need to clarify the role of women in this scenario.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Genetics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Reproduction</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Health care allocation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">IVF</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">PGD</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ectogenesis</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Science and engineering ethics</subfield><subfield code="d">Springer Netherlands, 1995</subfield><subfield code="g">25(2017), 4 vom: 02. Feb., Seite 1007-1016</subfield><subfield code="w">(DE-627)19230397X</subfield><subfield code="w">(DE-600)1304534-9</subfield><subfield code="w">(DE-576)051378167</subfield><subfield code="x">1353-3452</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:25</subfield><subfield code="g">year:2017</subfield><subfield code="g">number:4</subfield><subfield code="g">day:02</subfield><subfield code="g">month:02</subfield><subfield code="g">pages:1007-1016</subfield></datafield><datafield tag="856" ind1="4" ind2="1"><subfield code="u">https://doi.org/10.1007/s11948-017-9875-5</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_OLC</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-TEC</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-CHE</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-MAT</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-TGE</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">25</subfield><subfield code="j">2017</subfield><subfield code="e">4</subfield><subfield code="b">02</subfield><subfield code="c">02</subfield><subfield code="h">1007-1016</subfield></datafield></record></collection>
|
| score |
7.4019337 |